Prenatal Genetic Testing Options

Angie C. Jelin, Katelynn G. Sagaser, Louise Wilkins-Haug

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


All patients should be offered prenatal screening and diagnosis. Testing options depend on many factors, including patient age, family history, and patient preference. Options are rapidly changing with emerging technology. Aneuploidy screening options include ultrasound, maternal analytes, and cell-free DNA. Prenatal chromosomal microarray is the recommended diagnostic test for patients with anomalies visualized on prenatal ultrasound. Prenatal whole exome sequencing is clinically available but is limited by challenges with counseling, interpretation, and turn-around time. Future technologies are emerging and may soon allow for translation of prenatal diagnosis to in utero therapy.

Original languageEnglish (US)
Pages (from-to)281-293
Number of pages13
JournalPediatric Clinics of North America
Issue number2
StatePublished - Apr 1 2019


  • Cell-free DNA screening
  • Noninvasive prenatal testing
  • Prenatal diagnosis
  • Prenatal genetic testing

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Prenatal Genetic Testing Options'. Together they form a unique fingerprint.

Cite this